M
Masashi Mizokami
Researcher at Nagoya City University
Publications - 684
Citations - 37168
Masashi Mizokami is an academic researcher from Nagoya City University. The author has contributed to research in topics: Hepatitis B virus & Hepatitis C virus. The author has an hindex of 85, co-authored 650 publications receiving 34868 citations. Previous affiliations of Masashi Mizokami include National Institute of Advanced Industrial Science and Technology & University of Florida.
Papers
More filters
Journal ArticleDOI
Effect of Coffee and Green Tea Consumption on the Risk of Liver Cancer: Cohort Analysis by Hepatitis Virus Infection Status
Manami Inoue,Norie Kurahashi,Motoki Iwasaki,Taichi Shimazu,Yasuhito Tanaka,Masashi Mizokami,Shoichiro Tsugane +6 more
TL;DR: It is suggested that coffee consumption may reduce the risk of liver cancer regardless of HCV and HBV infection status, whereas green tea may not reduce this risk.
Journal ArticleDOI
SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.
Naoki Yamamoto,Yasuo Ariumi,Nao Nishida,Rain Yamamoto,Georg Bauer,Takashi Gojobori,Kunitada Shimotohno,Masashi Mizokami +7 more
TL;DR: Analysis of genetic factors associated with SARS-CoV-2 infection with a focus on angiotensin-converting enzyme (ACE)-related genes suggests that the ACE1 II genotype may influence the prevalence and clinical outcome of CO VID-19 and serve as a predictive marker for COVID-19 risk and severity.
Journal ArticleDOI
Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C.
Etsuro Orito,Masashi Mizokami,Kaoru Suzuki,Ken-ichi Ohba,Tomoyoshi Ohno,Masamiki Mori,Katsuo Hayashi,Koji Kato,Shiro Iino,Johnson Y.N. Lau +9 more
TL;DR: To determine the virological factors associated with a favorable long‐term response to interferon‐α (IFN) therapy in chronic hepatitis C virus (HCV) infection, 61 Japanese patients with chronic HCV infection were treated with IFN for 24 weeks and followed for 8 to 16 months after cessation of therapy.
Journal ArticleDOI
Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study
Man-Fung Yuen,Yasuhito Tanaka,Masashi Mizokami,John Chi-Hang Yuen,Danny Ka-Ho Wong,He-Jun Yuan,Siu-Man Sum,Annie On-On Chan,Benjamin C.Y. Wong,Ching-Lung Lai +9 more
TL;DR: There was a significantly higher prevalence of both genotype C and CP mutations in patients with HCC, and the association between HBV genotypes C and HCC was probably not genuine but was due to the high percentage of CP mutationsIn patients with genotypeC.
Journal ArticleDOI
Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India
Arup Banerjee,Fuat Kurbanov,Sibnarayan Datta,Partha K. Chandra,Yasuhito Tanaka,Masashi Mizokami,Runu Chakravarty +6 more
TL;DR: Using the complete genome analyses this study has confirmed circulation of the genotype C in Eastern part of India and demonstrated considerable genotypic heterogeneity of the Indian genotype D.